TABLE 5.
Characteristic | Multivariate OR (95% confidence interval) for rpoB mutationa |
|
---|---|---|
S450L | L430P | |
Sex | ||
Female | 1.09 (0.83–1.42) | 0.46 (0.23–0.95) |
Male | 1.0 | 1.0 |
Age (yrs) | ||
0–24 | 1.0 | 1.0 |
25–34 | 1.14 (0.76–1.70) | 0.61 (0.22–1.65) |
35–44 | 1.03 (0.67–1.57) | 1.53 (0.57–4.08) |
45+ | 1.26 (0.80–2.01) | 0.57 (0.17–1.91) |
Drug resistance profile | ||
MDR | 5.03 (3.66–6.85) | 1.0 |
RMR | 1.0 | 12.84 (6.33–26.03) |
HIV status | ||
Negative | 1.0 | 1.0 |
Positive | 0.88 (0.64–1.22) | 0.70 (0.32–1.52) |
Unknown | 1.37 (0.42–4.43) | 3.06 (0.32–29.01) |
Previous TB treatment | ||
No | 1.0 | 1.0 |
Yes | 1.06 (0.80–1.42) | 0.40 (0.20–0.79) |
Unknown | 1.44 (0.50–4.12) | |
Yr diagnosed | ||
2008–2012 | 1.0 | 1.0 |
2013–2017 | 0.82 (0.63–1.06) | 1.16 (0.60–2.26) |
Boldface indicates statistical significance.